Stock Price
24.27
Daily Change
-0.90 -3.58%
Monthly
-5.20%
Yearly
1.17%
Q1 Forecast
23.84

Celldex Therapeutics reported $-73.62M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 1.45B 4.26B Sep/2025
Amgen USD 3.96B 464M Dec/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Celldex Therapeutics USD -73.62M 9.76M Sep/2025
Glaxosmithkline GBP 3.76B 1.69B Sep/2025
Pfizer USD 4.65B 71M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025